Cleared Traditional

K062746 - FERRITIN-LATEX

K062746 is an FDA 510(k) clearance for FERRITIN-LATEX, manufactured by Medicon Hellas S.A. The device is a Class 2 Immunology device with product code DBF cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K062746 · Medicon Hellas S.A · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2006
Decision
67d
Days
Class 2
Risk

K062746 is an FDA 510(k) clearance for the FERRITIN-LATEX, MODELS 1418-2070, 1418-0279. Classified as Ferritin, Antigen, Antiserum, Control (product code DBF), Class II - Special Controls.

Submitted by Medicon Hellas S.A (Gerakas, Attiki, GR). The FDA issued a Cleared decision on November 20, 2006 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5340 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medicon Hellas S.A devices

FDA 510(k) Submission Details - K062746

510(k) Number K062746 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 2006
Decision Date November 20, 2006
Days to Decision 67 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 104d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DBF Device Classification - Class 2, Special Controls

Product Code DBF Ferritin, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBF Ferritin, Antigen, Antiserum, Control

All 65
Devices cleared under the same product code (DBF) and FDA review panel - the closest regulatory comparables to K062746.
ADVIA CHEMISTRY FERRITIN (FRT) METHOD
K110736 · Siemens Healthcare Diagnostics, Inc. · Aug 2011
TINA-QUANT FERRITIN GEN. 4
K100538 · Roche Diagnostics · Jun 2010
BECKMAN COULTER FERRITIN REAGENT, MODEL: OSR61203
K092505 · Beckman Coulter, Inc. · Dec 2009
K-ASSAY FERRITIN (2) & FERRITIN CALIBRATOR SET
K050944 · Kamiya Biomedical Co. · Dec 2005
QUANTEX FERRITIN
K040879 · Instrumentation Laboratory CO · May 2004
FERRITIN GENERATION 2
K031650 · Roche Diagnostics Corp. · Jul 2003